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Purpose/Objective: Motion management is a major challenge 
in abdominal SBRT. We present our study of SBRT for primary 
or secondary liver tumors using intrafraction motion review 
(IMR) which allows simultaneous KV information and /MV 
delivery to synchronize the beam during gated RapidArc 
treatment. 
Materials and Methods: Between May 2012 and April 2014, 25 
consecutive patients were treated with curative-intent liver 
SBRT. All patients were treated using gated RapidArc 
technique with a Varian Novalis Truebeam STx linear 
accelerator. An isotropic margin of 5mm around the ITV was 
used to create the PTV. Mean PTV volume was 117.81 cc. 
Dose prescription ranged from 40 to 50 Gy in 5 to 10 
fractions. The prescribed dose and number of fractions were 
chosen depending on hepatic function, irradiated liver 
volume and dose-volume histograms results. All patients were 
analysed for toxicity. Twenty-three patients with a minimal 
follow-up of six months were analysed for local control. 
Results: With a median follow-up of 10 months, the 
treatment was well tolerated and no patient presented RILD, 
perforation or gastrointestinal bleeding. Acute toxicity 
consisted on 3 patients with G1 abdominal pain, 1 with G1 
nausea, 8 with G1 asthenia and 1 with G2 asthenia.  
In-field local control was 91.3%, with 5 complete responses 
(21.7 %), 9 partial responses (39.1 %) and 7 stabilizations 
(30.4 %). 2 patients evolved 'in field'. 3 patients had an 
intrahepatic progression 'out of field'. 
Conclusions: The clinical tolerance and oncological outcomes 
were favorable when using Image-guided liver SBRT with real-
time adaptive tumor gating. 
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Purpose/Objective: Radiotherapy induced xerostomia (RIX) is 
the most common permanent side effect of radiotherapy (RT) 
to the head and neck (H&N) with no effective treatment.  
LMS-611 is a mimetic of a natural lamellar body which has 
been shown to have the potential to reduce the ‘stickiness’ 
of oral cavity secretions following RT. 
Our pre-clinical study was designed as an ex vivo, efficacy, 
proof of concept study as a preparatory step towards our 
clinical study of LMS-611 in RIX. 
Materials and Methods: Patients with H&N cancer who were 
booked for RT or chemoRT (CRT) as primary treatment were 
recruited.  
Patient reported xerostomia scores were collected using the 
Groningen RIX (GRIX) questionnaire at baseline, weeks 2, 4 
and 6 of radiotherapy. Saliva samples were also collected and 
adhesiveness and viscosity tested by assessing time taken to 
travel 5cm on an inclined plane (IP). LMS-611 was added to 
saliva samples and IP test repeated. 
Results: 30 patients were enrolled. All patients had a 
pathologically confirmed diagnosis of squamous cell 
carcinoma (SCC) oropharynx. Mean age 54.8 years, range 42-
67. 80% were male and the majority stage III and IV disease 
(96.6%). 90% received CRT. 
The mean IP test results (seconds) are as follows baseline 
31.3; week 2 49.7; week 4 51.1; week 6 55.7 indicating 
increasing saliva adhesiveness and viscosity as RT progresses. 
The increase was significant from baseline to week 2 with 
only moderate increases from week 2 to 4 and week 4 to 6. 
Wide inter-patient variability was seen at baseline. 
GRIX scores increased as RT progressed, see figure. 
Differences between GRIX scores at weeks 2, 4 and 6 were 
statistically significant when compared with pre-treatment 
scores. Modest variability in GRIX scores was seen at baseline 
and this remained constant. 
 
 
The IP test results were compared with GRIX scores, 
Spearman Correlation Co-efficient was -0.06 at baseline, 0.25 
at week 2, 0.12 at week 4 and 0.08 at week 6, therefore no 
relevant correlation was seen. 
The addition of saline, LMS-611 2.5mg/ml or 5mg/ml to the 
saliva samples does not reduce saliva adhesiveness and 
viscosity. However, when LMS-611 in concentrations of 
10mg/ml and 20mg/ml are added a significant reduction is 
seen in the IP test (not shown). Analysing the inclined plane 
results as survival data separately for each time point and 
overall adjusting for week of RT demonstrates this 
statistically significant difference see table.  
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Conclusions: Saliva becomes more visco-adhesive and patient 
reported xerostomia worsens as RT progresses. However, 
there is no relevant correlation between objective and 
subjective measures of xerostomia. The addition of LMS-611 
to thick, sticky saliva restores its fluidity ex-vivo at 
concentrations of 10mg/ml and 20mg/ml.  
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Purpose/Objective: To assess the impact in quality of life of 
the use of intranasal fentanyl in pectin (INFP) as a treatment 
for intake related breakthrough pain episodes in patients 
presenting with radiation induced mucositis. 
Materials and Methods: As part of the prospective 
observational GIC-FEN-2012-01 study (NCT02050503), quality 
of life was evaluated using the Spanish version of the EORTC 
QLQ-C30 questionnaire prior to INFP titration (after proper 
baseline pain control with modified release opioids) and 
following at least ten episodes of intake related breakthrough 
pain treated with the dose of INFP determined in titration. 
Fifty five patients presenting with oropharyngeal mucositis 
(41.8% grade 3) with controlled baseline pain were initially 
enrolled in this study. Thirty three patients underwent 
titration successfully and completed at least ten treated 
episodes of intake related breakthrough pain. QLQ-C30 scores 
before and after the introduction of INFP were compared in 
that subgroup. 
Results: Raw scores of the outcome of QLQ-C30 were 
analysed. In functional scales, significant differences were 
observed in role functioning (p<0.001), emotional functioning 
(p=0.005), cognitive functioning (p<0.001) and social 
functioning (p=0.014). In symptoms scales/items, significant 
differences were observed nausea and vomiting (p=0.002), 
dyspnoea (p<0.001) and appetite loss (p=0.044), constipation 
(p=0.002), diarrhoea (p<0.001) and financial difficulties 
(p<0.001). Significant differences were also observed in 
global health status score. Finally, significant differences 
were detected in overall standardised QLQ-C30 score 
(p<0.001). 
Conclusions: Quality of life was improved after the addition 
of INFP as a treatment of intake related breakthrough pain 
episodes to patients presenting with radiation induced 
oropharyngeal mucositis. Data regarding effectiveness, safety 
and toxicity profile is currently under analysis as part of the 
GIC-FEN-2012-01 study. 
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Purpose/Objective: To evaluate the association of target 
motion with target size (GTV), location and Child-Pugh score 
in Stereotactic Body Radiation Therapy (SBRT) of liver cancer 
by CyberKnife. 
Materials and Methods: Translational motion data of 146 
liver cancer patients, who were previously treated with free 
breathing under tumor tracking, were analyzed. Before 
treatment 3-8 gold fiducial markers (0.8x5mm) were 
implanted near target in order to be tracked by the tumor 
tracking system. Target motion data was automatically 
recorded in the log files of motion tracking system. Each of 
the following clinical factors was evaluated to determine its 
correlation to the amplitude of movement: target location 
(liver lobe), Child Pugh score, GTV size, and intra-fraction 
treatment time. 
Results: Target location was found correlated with the 
translational motion in Superior / Inferior (SI) (p=0.021) and 
Left / Right (LR) directions (p=0.007) but not Anterior / 
Posterior (AP) direction (p=0.398). The correlation of Child 
Pugh score and GTV size with target motions in SI, LR and AP 
directions were not significant. Intra-fraction treatment time 
significantly affected target translational motion in SI 
(p=0.02) and LR (p=0.005), while it was insignificant in AP-
direction (p=0.085). However, the correlation was fairly weak 
with R-square = 0.037 (SI) and 0.055 (LR) respectively. 
Conclusions: Analysis of the treatment log files in SBRT of 
liver cancer patients demonstrated that the target motions in 
SI and LR directions caused by respiratory motion were 
correlated with the location of target. The change in target 
motion amplitude showed no apparent relationship with 
Child-Pugh scores and GTV sizes, but a fairly weak 
relationship with the intra-fraction treatment time. 
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Purpose/Objective: Bleeding is a frequent symptom in 
patients with advanced cancer. Palliative radiotherapy (RT) is 
one of the treatment options to manage bleeding. Although 
